None listed
Conditions
Interventions
Intervention1: Minimalist Spot Pigmentation Corrector: Manufactured by: Uprising Science Private Limited
Marketed By: Minimalist
Mode of Usage: The test product should be applied to clean skin. A smal
Sponsors
Uprising Science Pvt. Ltd.,
Eligibility
Inclusion criteria
Inclusion criteria: Age: between 20 to 65 years at the time of consent. 2) Sex: Adult male and female having facial hyperpigmentation and dark spots such as tan, acne marks, sunspots, age spots, uneven skin tone on face. 3) Females of childbearing potential should have a self-reported negative urine pregnancy test at the time of screening visit. 4) Participants with Fitzpatrick Skin Types III to V, indicating moderate to dark skin tones. 5) Participants should not have used any cosmetic, nutraceutical or therapeutic products for dark spots in last 3 months. 6) Participants must be willing to stop using any cosmetics or any medical products for dark spots for the duration of the study. 7) Participants are not allowed to participate in any other study until this study is complete. 8) Participants must be willing and able to follow the study directions and to return for all specified visits with the product. 9) Participants must agree to record each use of the test products in the participant s diary card on daily basis. 10) Participants must agree to record medication use during the study.
Exclusion criteria
Exclusion criteria: Participants who are on steroids for last six months. 2) Participants who have used any cosmetic, nutraceutical or therapeutic products for skin last three months. 3) Participants who are on product which contains kojic acid, glycolic acid, niacinamide, alpha arbutin, Vitamin C and other skin product.Participants with other dermatologic diseases whose presence or products could interfere with the assessment of study. 5) Participants with any active dermatological disease on the face (e.g., eczema, psoriasis, infection). 6) History of hypersensitivity to sunscreens or cosmetic products. 7) Use of depigmenting products (e.g., chemical peels, lasers, hydroquinone-based products) within 4 weeks prior to baseline. 8) Participants that are pregnant and/or breastfeeding. 9) The participant has a known allergy or sensitivity to product ingredients. 10) Participants if do not agree to limit sun exposure to affected areas such as face during prolonged sun exposure. 11) The participant is currently taking or has taken any medication, which the Investigator believes may influence the interpretation of the data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of the test product in terms of change in skin melanin from baseline before usage and after usage of the test product, within the product group and between product and control group.Timepoint: baseline before usage of the test product on Day 01 and after usage of the test product on Day 30 ( 2 Days), Day 60 ( 2 Days) and Day 90 ( 2 Days) | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of the test product in terms of change in skin colour parameters - L, a, b, and ITA from baseline before usage and after usage of the test product, within the product group and between product and control group.Timepoint: before usage of the test product on Day 01 and after usage of the test product on Day 30, Day 60 and Day 90;To evaluate the effectiveness of the test product in terms of change in skin Erythema from baseline before usage and after usage of the test product, within the product group and between product and control group.Timepoint: before usage of the test product on Day 01 and after usage of the test product on Day 30, Day 60 and Day 90;To evaluate the effectiveness of the test product in terms of change in skin melasma and severity from baseline before usage and after usage of the test product, within the product group and between product and control group.Timepoint: before usage of the test product on Day 01 and after usage of the test product on Day 30, Day 60 and Day 90;To evaluate the effectiveness of the test product in terms of change in Product Perception Questionnaire from baseline before usage and after usage of the test product, within the product group and between product and control group.Timepoint: before usage of the test product on Day 01 and after usage of the test product on Day 30, Day 60 and Day 90 | — |
Countries
India
Contacts
Public ContactDr Maheshvari Patel
NovoBliss Research Private Limited
Outcome results
None listed